Research and Markets: Global Alzheimer Market Report: 2015 Edition

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/84xggm/global_alzheimer) has announced the addition of the "Global Alzheimer Market Report: 2015 Edition" report to their offering.

The report, Global Alzheimer Market analyzes the currently prevailing condition of the market along with its future scope of development. The global market along with specific markets of the U.S., Europe (including the UK) and Asia-Pacific are being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.

The current market for Alzheimer's disease drugs is limited as only few drugs have been approved thus, defining a healthy scope of introduction of new drugs in the market in the coming years. The healthcare costs associated with Alzheimer's are also anticipated to rise considerably since only limited treatment options are available in the market. The Alzheimer market expects introduction of innovative small molecules, biopharmaceuticals and disease modifying agents that would help transform the pattern of Alzheimer's disease.

Increasing ageing population, growing population of women, rising life expectancy, increasing healthcare expenditure, improving economic conditions, and increasing global spending on medicines are some of the major factors contributing to the growth of Alzheimer's disease market. However, the growth of the market is hindered by certain challenges including lack of availability of effective treatment options, problems in detection and diagnosis, and insufficient research funding.

Market Dynamics

Growth Drivers

  • Growing Ageing Population
  • Increasing Population of Women
  • Rising Life Expectancy
  • Rising Healthcare Expenditure
  • Improving Economic Conditions
  • Increasing Global Spending on Medicines

Key Trends and Developments

  • Pipeline Drugs under Development
  • Alzheimer as a Major Cause of Deaths in the U.S.
  • Development of 5-HT6 Antagonists
  • Higher Lifetime Risk for Women

Challenges

  • Lack of Effective Treatment Options
  • Insufficient Research Funding
  • Difficulty in Detection and Diagnosis

Key Topics Covered:

1 Overview

2. Market Analysis

3. Regional Markets

4. Market Dynamics

5. Competitive Landscape

6. Company Profiles

- Forest Laboratories, Inc.

- Johnson & Johnson

- Novartis

- Pfizer, Inc.

- Roche Holdings

For more information visit http://www.researchandmarkets.com/research/84xggm/global_alzheimer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System